Role of Ayurvedic medicines in Dadru

STUDY OF TVAKA SHARIR AND EVALUATION OF THE EFFICACY OF EG 5 LEPA IN THE MANAGEMENT OF DADRU KUSHTHA WITH SPECIAL REFERENCE TO FUNGAL DERMATOPHYTOSIS: A RANDOMISED CONTROL TRIAL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043469

Enrollment

Registered

2022-06-24

Start date

Unknown

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L303- Infective dermatitis Health Condition 2: L08- Other local infections of skin andsubcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient willing to participate in clinical trial. 2. The patients of either sex having age between 18 - 60 years. 3. The patients having clinical signs and symptoms of Dadru Kushtha with special reference to Fungal Dermatophytosis.

Exclusion criteria

Exclusion criteria: 1. Patients with long-term history of steroid (Internal and Topical) and cytotoxic treatment. 2. Patients having concomitant illness like uncontrolled Hypertension, Diabetes Mellitus, HIV, Malignancy, etc. 3. Patients having other associated skin disease like eczema, secondary bacterial infection, etc. 4. Patient participated in any clinical trial with in last six months. 5. Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
Change in 12-item pruritus severity scale.Timepoint: 2 weeks and 4 weeks	—

Secondary

Measure	Time frame
â?¢ Changes in lab investigations, size of lesions and number of lesions. Timepoint: ONE AND HALF YEAR	—

Countries

India

Contacts

Public ContactProf Sunil Kumar

National Institute of Ayurveda deemed to be university (De-novo) Jaipur

drsunilkumarbhu@gmail.com9414077592

Outcome results